GJP-16360-96518
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 775 / TX
- Registered
- 2021-01-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Registered in v-safe
-
2021-01-25
Dose 1 — Pfizer-BioNTech
- 2021-01-25
-
2021-01-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
-
2021-02-01
Survey response — day 7, dose 1MedDRA: Respiratory tract congestion — Feeling: Fair · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Congestion,MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-02-08
-
2021-02-12
Dose 2 — Pfizer-BioNTech
- 2021-02-24
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-21
- 2021-05-16
- 2021-08-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 3 — day 7, dose 1
Systemic reaction (other): Congestion,
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release